compared to Q2-2022 operating performance. Revenue from Sales for Q2/2023 and Q2/2022 was 826.57 million baht and 631.53 million baht, respectively. Increased 195.05 million baht or 30.88% when compared with
compared to Q2-2022 operating performance. Revenue from Sales for Q2/2023 and Q2/2022 was 826.57 million baht and 631.53 million baht, respectively. Increased 195.05 million baht or 30.88% when compared with
Million Courageous Deeds for the Land Project organized by the Foundation for the Thai Society as to admire and support the successful management that can lead the organization to the sustainable success
Million Courageous Deeds for the Land Project organized by the Foundation for the Thai Society as to admire and support the successful management that can lead the organization to the sustainable success
). Revenue has increased 1.26 million baht (ratio 2.45%) due to sale local increased by 0.96 million baht, increasing return estimates 0.46 million baht, rental income increased 0.54 million baht, other
% because of the follow main reasons. 1. Revenue from hospital operations increased by Baht 52.43 million or 8.94 % due to in Q3/2018 the revenue from general patient increased. 2. Cost of hospital operations
decreased. Meanwhile, administrative expenses were increased due to success fee and amortization of rights to power purchase agreement and rights to fuel purchase agreement of Paju ES. Quezon (Include PEPOI
%. These caused, revenue from sales of export increased about 26% and revenue from sales of domestic decreased about 11%. Analysis of Profit of company and its subsidiaries The Q3/2017, the company and its
, increased from Baht 341.3 million in the same period of the year 2016 or increased by 23.1 percent due to the same store sales of the company increased by 21.2 percent. The Company’s net profit was increased
caused, revenue from sales of export increased about 21% and revenue from sales of domestic decreased about 12%. Analysis of Profit of company and its subsidiaries In 2017, the company and its subsidiaries